HIGHLIGHTS
- What: Dupilumab safely and effectively managed EoG concomitant with severe asthma.
- Who: Tomohito Takeshige from the Department of Respiratory Medicine, Juntendo University Nerima Hospital, ‑1‑1, Takanodai, Nerima‑ku, Tokyo, ‑8521, Japan have published the Article: Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma, in the Journal: (JOURNAL)
SUMMARY
Eosinophilic gastrointestinal diseases (EGIDs) are chronic immune-mediated inflammatory disorders characterized by gastrointestinal (GI) symptoms and eosinophilic inflammation in particular regions of the GI tract without known etiology of eosinophilia. Any other site of involvement is referred to as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.